Sangamo and Astellas Announce Capsid License Agreement to Deliver Genomic Medicine for Neurological Diseases

Click here to view

Presentation

Poster: Epigenetic Regulation of Human Prion Expression as a Potential One-Time Treatment for Prion Disease

Download PDF